Future Health Care Equity ETF (GDOC)
NYSEARCA: GDOC · Real-Time Price · USD
33.33
+0.11 (0.34%)
Nov 22, 2024, 2:48 PM EST - Market closed
0.34% (1D)
| Assets | $21.42M |
| Expense Ratio | 0.75% |
| PE Ratio | 38.69 |
| Shares Out | 650,000 |
| Dividend (ttm) | $0.18 |
| Dividend Yield | 0.54% |
| Ex-Dividend Date | Dec 26, 2023 |
| Payout Ratio | 20.78% |
| 1-Year Return | +11.33% |
| Volume | 339 |
| Open | 33.33 |
| Previous Close | 33.22 |
| Day's Range | 33.33 - 33.33 |
| 52-Week Low | 29.85 |
| 52-Week High | 37.23 |
| Beta | 0.89 |
| Holdings | 41 |
| Inception Date | Nov 9, 2021 |
About GDOC
Fund Home PageThe Future Health Care Equity ETF (GDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to equities of companies that are driving innovation in healthcare globally. GDOC was launched on Nov 9, 2021 and is issued by Goldman Sachs.
Asset Class Equity
Category Health
Stock Exchange NYSEARCA
Ticker Symbol GDOC
ETF Provider Goldman Sachs
Top 10 Holdings
55.19% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 10.17% |
| Boston Scientific Corporation | BSX | 7.38% |
| Intuitive Surgical, Inc. | ISRG | 5.91% |
| AbbVie Inc. | ABBV | 5.41% |
| UnitedHealth Group Incorporated | UNH | 5.36% |
| Insulet Corporation | PODD | 4.80% |
| Amgen Inc. | AMGN | 4.20% |
| Merck & Co., Inc. | MRK | 4.02% |
| Abbott Laboratories | ABT | 3.99% |
| Novo Nordisk A/S | NOVO.B | 3.95% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 26, 2023 | $0.179 | Jan 2, 2024 |
| Sep 26, 2022 | $0.00003 | Sep 30, 2022 |
News
Goldman Sachs is building on the disruptive investing theme with a trio of new ETFs
Goldman Sachs Group is offering investors new ways to seek equity gains from disruptive companies, with its asset management business launching three exchange-traded funds focused on secular growth tr...
3 years ago - Market Watch